Federated Hermes, Inc. 13D and 13G filings for Minerva Neurosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-29 08:29 am Purchase | 2025-12-22 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 9,392,275 19.860% | 8,041,000 (+595.07%) | Filing |
| 2025-10-28 4:39 pm Unchanged | 2025-10-21 | 13D | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,351,275 19.320% | 0 (Unchanged) | Filing |
| 2024-01-18 10:21 am Purchase | 2023-12-31 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,351,275 19.320% | 150,000 (+12.49%) | Filing |
| 2023-02-01 11:16 am Purchase | 2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,201,275 22.500% | 1,201,275 (New Position) | Filing |